CBClarissa Bueno

Clarissa Bueno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clarissa Bueno has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sleep and Rhythmic Profile After Pineal Gland Removal in Humans

    by Renata de Andrade Prado Gobetti, Clarissa Bueno, Letícia M. S. F. A. Soster, Anna Carolina de Campos de Barros Luvizotto Monazzi, Fernanda Gaspar Do Amaral, Andréa Maria Capellano, Nasjla Saba da Silva, José Cipolla‐Neto

    Melatonin, a hormone produced by the pineal gland, is classically described as a central circadian modulator. However, the impact of its absence on circadian rhythmicity in humans remains poorly understood. Pinealectomised patients, in whom melatonin secretion is chronically suppressed, represent a valuable clinical model to investigate the physiological role of this hormone in sleep and temporal organisation. This study evaluated sleep quality and sleep disorders, as well as circadian rhythmicity, in 17 individuals who underwent surgical or radiotherapeutic treatment for pineal tumours and exhibited confirmed absence of circulating melatonin. Participants were assessed through structured clinical interviews, standardised sleep questionnaires, sleep diaries and actigraphy recording for a minimum of 15 consecutive days. Rhythmic analysis was performed for sleep/wakefulness and rest/activity data. Mild nocturnal sleep symptoms were reported, but diurnal complaints were frequent. Despite the chronic absence of melatonin, all subjects maintained a 24‐h sleep/wake cycle, and none met criteria for circadian sleep/wake disorders. We conclude that melatonin demonstrated not to be crucial for the maintenance of the circadian sleep/wake cycle in individuals with chronic melatonin absence due to pineal gland removal and minor sleep complaints are present in this population. Other synchroniser mechanisms possibly involving non‐photic entrainment might play an important role in the maintenance of the circadian rhythm.


  • Open Access

    Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi–Goutières Syndrome Phenotype

    by Isabella Peixoto de Barcelos, Clarissa Bueno, Luís Filipe S. Godoy, André Pessoa, Larissa A. Costa, Fernanda C. Monti, Katiane Souza-Cabral, Clarice Listik, Diego Castro, Bruno Della-Ripa, et al.

    Objective: To report a series of atypical presentations of Aicardi–Goutières syndrome. Methods: Clinical, neuroimaging, and genetic data. Results: We report a series of six unrelated patients (five males) with a subacute loss of developmental milestones, pyramidal signs, and regression of communication abilities, with onset at ages ranging from 7 to 20 months, reaching a nadir after 4 to 24 weeks. A remarkable improvement of lost abilities occurred in the follow-up, and they remained with residual spasticity and dysarthria but preserved cognitive function. Immunization or febrile illness occurred before disease onset in all patients. CSF was normal in two patients, and in four, borderline or mild lymphocytosis was present. A brain CT scan disclosed a subtle basal ganglia calcification in one of six patients. Brain MRI showed asymmetric signal abnormalities of white matter with centrum semi-ovale involvement in five patients and a diffuse white matter abnormality with contrast enhancement in one. Four patients were diagnosed and treated for acute demyelinating encephalomyelitis (ADEM). Brain imaging was markedly improved with one year or more of follow-up (average of 7 years), but patients remained with residual spasticity and dysarthria without cognitive impairment. Demyelination relapse occurred in a single patient four years after the first event. Whole-exome sequencing (WES) was performed in all patients: four of them disclosed biallelic pathogenic variants in RNASEH2B (three homozygous p.Ala177Thr and one compound heterozygous p.Ala177Thr/p.Gln58*) and in two of them the same homozygous deleterious variants in RNASEH2A (p.Ala249Val). Conclusions: This report expands the phenotype of AGS to include subacute developmental regression with partial clinical and neuroimaging improvement. Those clinical features might be misdiagnosed as ADEM.